• Follow the Money: Universal Flu Vaccine, Full-Length Single-Molecule Protein Sequencer, More

    Jul 30 | Bio-IT World | Centivax plans to get their first universal flu vaccine through a Phase I clinical trial; Portal Biotech will use their nanopore-based platform technology to deliver rapid, full-length, single-molecule protein characterization and expand its R&D, engineering, and data-science teams; and more. More

  • Arab Pangenome Reference Published

    Jul 29 | Bio-IT World | Researchers have published the first draft Arab pangenome reference, the UAE Pangenome Reference (UPR) based on 53 individuals of diverse Arab ethnicities residing in the United Arab Emirates. The work was done at the Center for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates and was published in Nature Communications last week. More

  • Multiomics Platform Integration Advances Cancer Treatment Predictions

    Jul 24 | Bio-IT World | A groundbreaking biotech collaboration in Switzerland has successfully integrated nine molecular analysis platforms to create a comprehensive tumor profiling system that predicts optimal cancer treatments—showcasing how next-generation sequencing can be enhanced through multiomics approaches for transformative clinical outcomes. More

  • Innovative Practices Award for NHS England, IQVIA Privacy Protection Platform

    Jul 23 | Bio-IT World | To support patient privacy while providing data accessibility for organizations, the National Health Service (NHS) England with IQVIA developed NHS PET (Privacy Enhancing Technology) as a secure, scalable solution for patient data. The work earned NHS and IQVIA one of four Innovative Practices Awards at this year’s Bio-IT World Conference & Expo—an honor the judges christened the “Respect the Patient Award”. More

  • NIST Releases First Cancer Cell Line for Public Genomic Research

    Jul 22 | Bio-IT World | The National Institute of Standards and Technology (NIST) has released the first cancer cell line in its Genome in a Bottle (GIAB) consortium. The new resource features a pancreatic cancer tumor cell line along with corresponding normal tissue samples, all obtained with explicit patient consent for public genomic data sharing. More

  • The New Frontier in Alzheimer’s Prevention: AI-Powered Neurodiagnostic Solutions

    Jul 18 | Bio-IT World | Imagine sitting down for a routine checkup and learning you could prevent one of the most devastating diseases of our time before it ever occurs. For many families, diagnosis arrives only after noticeable confusion or memory loss disrupts daily life. By that point, much of the brain has already been damaged, and options for slowing decline are limited. More

  • A Popular Alzheimer’s Biomarker Found at High Levels in Newborns

    Jul 16 | Bio-IT World | In recent years, phosphorylated tau has garnered so much attention as one of the “bad guys” of Alzheimer’s disease that the scientific community may have developed a bit of tunnel vision. A medical doctor in Sweden seeks to remedy the situation as a “champion” of the biomarker based on the critical if forgotten physiological role it plays in the healthy human brain. More

  • Pharma Companies Finding Their Way with AI

    Jul 15 | Bio-IT World | Massive progress has been enabled by individual applications of artificial intelligence (AI) and machine learning (ML) in drug discovery, AlphaFold being one of the most prominent, due to their ability to predict the type of molecules that should have a positive impact on patient care. More

  • Trends from the Trenches: What a TV Scientist Knows About Teaching Science

    Jul 10 | Bio-IT World | David Hewlett, renowned for portraying Dr. Rodney McKay in the Stargate franchise, recently joined Trends from the Trenches podcast to discuss the fascinating intersection of Hollywood, science communication, and lifelong learning. Hewlett and host Ari Berman explore how entertainment can serve as a powerful gateway to scientific curiosity and innovation. More

  • From Physics to Longevity: How Gero’s ProtoBind-Diff Tool Reads Nature’s Hidden Drug Library

    Jul 09 | Bio-IT World | Consumer genomics pioneer 23andMe will be returning to its co-founder and former CEO as Anne Wojcicki’s TTAM Research Institute outbids Regeneron to buy 23andMe out of bankruptcy—as long as no more state attorneys general object. The current iteration of the sale is expected to close on July 8. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!